about
The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesisContribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancerStem cell antigen-1 (sca-1) regulates mammary tumor development and cell migration.Tumor-initiating function of nucleostemin-enriched mammary tumor cells.Genetic manipulation of individual somatic mammary cells in vivo reveals a master role of STAT5a in inducing alveolar fate commitment and lactogenesis even in the absence of ovarian hormones.Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.Stem/progenitor cells in mouse mammary gland development and breast cancer.Luminal epithelial cells within the mammary gland can produce basal cells upon oncogenic stress.Bcl-xL promotes metastasis independent of its anti-apoptotic activity.Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation.Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells--implications for pregnancy-induced protection against breast cancer.Scaffold Attachment Factor B1 (SAFB1) heterozygosity does not influence Wnt-1 or DMBA-induced tumorigenesisThe RCAS-TVA system for introduction of oncogenes into selected somatic mammary epithelial cells in vivo.The PR status of the originating cell of ER/PR-negative mouse mammary tumors.Breast tumor cell-specific knockout of Twist1 inhibits cancer cell plasticity, dissemination, and lung metastasis in mice.Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.ALK phosphorylates SMAD4 on tyrosine to disable TGF-β tumour suppressor functionsPTPN3 acts as a tumor suppressor and boosts TGF-β signaling independent of its phosphatase activityImmuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms
P50
Q28589724-4B10A11D-7C28-4AE8-BAC7-004B8F7D835AQ33728569-FB360541-0636-4E82-88D9-B96179EAF764Q34091056-DC02EC4A-A590-4797-84CD-AD7D031AF920Q34316303-2EFF70A0-1B26-4E10-B93D-6A77C3A1948DQ34485892-773F4663-A328-48DF-B292-79C024AE00DFQ34580042-E140B7E9-2D2E-412B-83F9-A59B322D701DQ36123668-E3488E23-4AED-44A0-B51E-D07521267D70Q36395533-2E3470C7-A708-4BCB-9634-066EEB2B010AQ36528864-32FF9838-AF1C-4D65-8F9E-C69CD59BA5DCQ36944749-137B9668-9515-48FC-9D85-E9BE824A6C81Q37109686-A3397361-18C2-4198-9FAB-28C26AA30551Q37158467-CBE3FD7E-684F-41FC-AF40-A5F934B4AFF9Q37638389-E95FBE50-913D-49CC-A773-A077D3C4EFC1Q40239612-4FB114F0-83D4-4E64-9D0D-A7F076646766Q42517464-D27F71EC-A305-4B37-B085-312069CA7531Q54978736-6617A496-800D-419E-908F-4A496C0AD5FAQ91143132-27966A50-781B-439C-9473-3F79ECBBB1E7Q91871853-78F7EA79-E699-4BE1-863F-5E570CBC890AQ92883114-1BA1C128-7523-4AC9-9157-9C7B0FADC5C5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yi Li
@ast
Yi Li
@en
Yi Li
@es
Yi Li
@nl
Yi Li
@sl
লি ই
@bn
type
label
Yi Li
@ast
Yi Li
@en
Yi Li
@es
Yi Li
@nl
Yi Li
@sl
লি ই
@bn
prefLabel
Yi Li
@ast
Yi Li
@en
Yi Li
@es
Yi Li
@nl
Yi Li
@sl
লি ই
@bn
P1053
A-7635-2009
P106
P31
P3829
P496
0000-0002-9976-518X
P569
2000-01-01T00:00:00Z